|Articles|May 6, 2003
Novartis and QTL win innovation award
Novartis Ophthalmics and QLT Inc. were awarded with the Helen Keller Prize for Innovation in Eye Care for their development of Visudyne (verteporfin for injection) therapy.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
UPDATE: STAAR postpones Alcon merger vote, Broadwood calls for removal of board members
2
Research supports that iron dysregulation may drive AMD
3
ONL Therapeutics randomizes first patient in phase 2 GALAXY trial evaluating xelafaslatide
4
Throwback Series: Managing bilateral diabetic macular edema early in practice
5













































.png)


